January 8, 2024
Five Cannabis Stocks with Potential for Growth and Stability
Confidence Amidst Market Upswing The first week of 2024 witnessed substantial stock price appreciation for the majority of the 30 stocks ranked weekly by Viridian Capital Advisors. Notably, the MSOS ETV surged by 12.84%, marking the sharpest uptick since the HHS announcement at the end of August. Surprisingly, the surge was not catalyzed by any specific news—just a market eager to believe following confirmation from the DEA that they are studying the issue of rescheduling. Despite optimism, Viridian Capital Advisors indicated a likelihood of DEA moving to schedule 3 to eliminate 280e benefits, but expressed skepticism about the possibility of